Abstract
Background
Though not yet the standard of care, lymphatic mapping is becoming more widely utilized by surgeons who care for women with breast cancer. The purpose of this study is to report the early experience of lymphatic mapping at a large NCI designated cancer center.
Methods
Beginning in 1997, selected newly diagnosed breast cancer patients at our institution have undergone lymphatic mapping. Blue dye and radiolabeled colloid were used as mapping agents. Patients were entered into a prospective database which recorded demographics, mapping characteristics and pathologic correlation.
Results
In total, 352 patients were entered into the study, and 312 (89%) had an identifiable sentinel lymph node at the time of definitive surgery. Eight surgeons contributed to the database, four of whom performed more than 30 lymphatic mapping procedures. 149 patients underwent complete axillary lymphadenectomy either as part of a validation study (68) or because of metastasis disease to the sentinel node (81). The false negative rate was 4%. The surgeon’s experience with the procedure was the only independent predictor of the ability to localize a sentinel node.
Conclusions
Sentinel lymphadenectomy at our institution is an accurate means of predicting the status of the draining nodal basin. Experience with the technique correlates with successful localization, but patient selection and an institutional commitment to the procedure are also critical for success.
Similar content being viewed by others
Abbreviations
- Uo:
-
Upper outer
- Ui:
-
Upper inner
- Lo:
-
Lower outer
- Li:
-
Lower inner
- Sa:
-
Sbareolar
- SNB:
-
Sentinel node biopsy
- ALND:
-
Axillary lymph node dissection
- CNB:
-
Core needle biopsy
- EB:
-
Excisional biospy
- FNA:
-
Fine needle aspiration
- PT:
-
Percutaneous
References
Krag D, Weaver D, Ashikaja T,et al: The sentenel node in breast cancer; A multicenter validation study.NEJM 339:941–946, 1998.
Giuliano AE, Kirgan DM, Guenther JM,et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg 220:391–401, 1994.
Albertini JJ, Lyman GH, Cox C,et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.JAMA 276:1818–1822, 1996.
O’hea BJ, Hill A, El-Shirbiny AM,et al: Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center.J Am Col Surg 186:423–427, 1998.
Giuliano AE, Jones RC, Brennan M,et al: Sentinel lymphadenectomy in breast cancer.J Clin Onc 15:2345–2350, 1997.
Veronesi U, Paganelli G, Galimberti V,et al: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative nodes.Lancet 349:1864–1867, 1997.
Barnwell JM, Arredondo MA, Kollmorgen D,et al: Sentinel node biopsy in breast cancer.Ann Surg Oncol 5:126–130, 1998.
Cote RJ, Peterson HF, Chaiwun RD,et al: Role of immunohistochemical detection of lymph-node metastasis in management of breast cancer.Lancet 354:896–900, 1999.
Guenther JM, Krishnamoorthy M, Tan LR: Sentinel lymphadenectomy for breast cancer in a community managed care setting.Can J from SA 3:336–340, 1997.
Burak WE, Walker MJ, Yee LD,et al: Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer.Am J Surg 177:445–449, 1999.
McMasters K, Wong SL, Turtle TM,et al: Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes.Ann Surg 231:724–731, 2000.
Cox CE, Pendas S, Cox JM,et al: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.Ann Surg 227:645–653, 1998.
Cody HS, Hill A, Tran KN,et al: Credentialing for breast lymphatic mapping: How many cases are enough?Ann Surg 229:723–728, 1999.
Author information
Authors and Affiliations
About this article
Cite this article
Zervos, E.E., Burak, W.E. Lymphatic mapping for breast cancer: experience at the Ohio State University. Breast Cancer 7, 195–200 (2000). https://doi.org/10.1007/BF02967460
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02967460